Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Iqvia Holdings Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IQV
New York
8731
https://ir.iqvia.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Iqvia Holdings Inc
Insiders At IQVIA Holdings Sold US$10m In Stock, Alluding To Potential Weakness
- Mar 25th, 2024 11:00 am
Why Is Tandem Diabetes Care (TNDM) Up 27.4% Since Last Earnings Report?
- Mar 22nd, 2024 3:30 pm
25 Countries With Limited Access To Healthcare
- Mar 20th, 2024 11:44 pm
Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today
- Mar 20th, 2024 12:01 pm
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
- Mar 15th, 2024 5:38 pm
IQVIA (IQV) Up 5.3% Since Last Earnings Report: Can It Continue?
- Mar 15th, 2024 3:30 pm
IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly
- Mar 15th, 2024 11:00 am
IQVIA (IQV) Gains From Global IT Framework, Liquidity Low
- Mar 13th, 2024 4:07 pm
Is There Now An Opportunity In IQVIA Holdings Inc. (NYSE:IQV)?
- Mar 11th, 2024 12:00 pm
Tandem Diabetes Care, Inc. (TNDM) Surges 9.6%: Is This an Indication of Further Gains?
- Mar 8th, 2024 11:19 am
Those who invested in IQVIA Holdings (NYSE:IQV) five years ago are up 79%
- Mar 7th, 2024 2:00 pm
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
- Mar 6th, 2024 9:15 pm
Should We Be Delighted With IQVIA Holdings Inc.'s (NYSE:IQV) ROE Of 22%?
- Mar 1st, 2024 1:00 pm
Veeva's Upside May Be Capped as Revenue Growth Slows
- Feb 27th, 2024 1:00 pm
IQVIA Publishes its 2023 Environmental, Social and Governance Report
- Feb 26th, 2024 1:00 pm
IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 32% Below Their Intrinsic Value Estimate
- Feb 26th, 2024 11:00 am
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
- Feb 23rd, 2024 2:00 pm
Insiders At IQVIA Holdings Sold US$5.3m In Stock, Alluding To Potential Weakness
- Feb 22nd, 2024 12:00 pm
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
- Feb 21st, 2024 9:15 pm
Results: IQVIA Holdings Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
- Feb 18th, 2024 12:20 pm
Scroll